Edwards–Patton–Dilly syndrome

From WikiMD's WELLNESSPEDIA

Edwards–Patton–Dilly Syndrome is a rare genetic disorder characterized by a range of physical and developmental anomalies. The syndrome is named after the researchers who first identified it, highlighting its unique clinical features and genetic background. This article provides an overview of Edwards–Patton–Dilly Syndrome, including its symptoms, causes, diagnosis, and treatment options.

Symptoms[edit]

The clinical manifestations of Edwards–Patton–Dilly Syndrome can vary significantly among affected individuals. Common symptoms include:

Causes[edit]

Edwards–Patton–Dilly Syndrome is a genetic disorder caused by mutations in a specific gene. The exact gene associated with the syndrome has not yet been definitively identified, making its genetic basis a subject of ongoing research. It is believed to follow an autosomal recessive inheritance pattern, meaning an individual must inherit two copies of the mutated gene (one from each parent) to be affected.

Diagnosis[edit]

Diagnosis is based on a combination of:

Although the specific gene(s) involved may not always be identified, genetic testing helps rule out other conditions and supports a clinical diagnosis.

Treatment[edit]

There is no cure for Edwards–Patton–Dilly Syndrome. Treatment focuses on managing symptoms and improving quality of life through a multidisciplinary approach. Management strategies include:

Prognosis[edit]

The prognosis for individuals with Edwards–Patton–Dilly Syndrome varies depending on:

Early intervention and comprehensive care can significantly improve outcomes and enhance the quality of life for those affected.

See Also[edit]



NIH genetic and rare disease info[edit]

Edwards–Patton–Dilly syndrome is a rare disease.





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.